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Summary  Radiofrequency  treatment  is  the  ﬁrst-choice  treatment  for  arrhythmias,  in  parti-
cular complex  arrhythmias  and  especially  atrial  ﬁbrillation,  due  to  the  greater  beneﬁt/risk  ratio
compared with  antiarrhythmic  drugs.  However,  complex  arrhythmias  such  as  atrial  ﬁbrillation
require long  procedures  with  additional  risks  such  as  X-ray  exposure  or  serious  complications
including  tamponade.  Given  this  context,  robotic  magnetic  navigation  is  a  technique  well  suited
to the  treatment  of  complex  arrhythmias,  on  account  of  its  efﬁcacy  and  reliability,  the  sig-
niﬁcant reduction  in  X-ray  exposure  for  both  patient  and  operator,  and  the  very  low  risk  of
perforation.  As  ongoing  developments  will  likely  improve  results  and  procedure  times,  this
technology will  become  one  of  the  most  advanced  for  treating  arrhythmias.
© 2012  Elsevier  Masson  SAS.  All  rights  reserved.
MOTS  CLÉS
Fibrillation  atriale  ;
Résumé  Le  traitement  par  radiofréquence  constitue  le  traitement  de  choix  des  arythmies
notamment  des  arythmies  complexes  avec  au  premier  plan  la  ﬁbrillation  auriculaire  du  fait  d’unAblation  ;
Troubles  du  rythme  ;
Robotique  ;
Stéréotaxis
bénéﬁce/risque  supérieur  à  celui  des  médicaments  antiarythmiques.  Cependant,  les  arythmies
complexes  comme  la  ﬁbrillation  atriale  nécessitent  des  temps  de  procédures  longs  d’où  des
risques supplémentaires  comme  l’exposition  aux  rayons  X  ou  les  risques  de  complications  graves
comme la  tamponnade.  Dans  ce  contexte,  le  système  de  traitement  des  troubles  du  rythme  par
navigation  magnétique  robotisée  s’impose  comme  une  technique  parfaitement  adaptée  aux
arythmies  complexes  du  fait  de  son  efﬁcacité,  de  sa  ﬁabilité,  de  la  réduction  signiﬁcative  de
Abbreviations: 3D, three-dimensional; AF, atrial ﬁbrillation; MNS, magnetic navigation system; RF, radiofrequency; RFA,
adiofrequency ablation.
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l’exposition  aux  rayons  X  pour  le  patient  et  l’opérateur  mais  aussi  par  un  risque  très  faible  de
perforation.  Des  développements  sont  en  cours  qui  devraient  encore  améliorer  les  résultats,
les temps  de  procédures  ce  qui  devrait  imposer  cette  technologie  comme  une  des  technologies
les plus  modernes  pour  traiter  les  troubles  du  rythmes.
© 2012  Elsevier  Masson  SAS.  Tous  droits  réservés.
Figure 1. Simulation of the examination table, with the active
position of the magnets in the presence of the patient.
Figure 2. Irrigated magnetic catheter with three magnets incor-
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Radiofrequency  (RF)  treatment  is  the  ﬁrst-choice  therapy
for  simple  arrhythmias,  considering  the  numerous  secondary
effects  and  low  efﬁcacy  of  antiarrhythmic  drugs  in  this  indi-
cation  [1].  Over  the  past  few  years,  RF  treatment  has  taken
a  decisive  place  in  the  treatment  of  complex  arrhythmias
and,  more  particularly,  in  the  treatment  of  atrial  ﬁbrillation
(AF)  [1—5]. For  these  particular  indications,  operators  must
be  experienced,  especially  in  manipulating  catheters  in  dif-
ﬁcult  clinical  situations,  which  may  lead  to  long,  tedious
and  potentially  risky  procedures  [2—5]. A  major  limitation
of  this  manual  method  is  caused  by  the  catheter  techno-
logy,  as  catheter  mobility  is  limited  by  the  transmission  of
the  torque,  depending  on  vessel  tortuosity,  orientation  of
the  catheter  in  the  heart  and  its  rigidity  or  instability.  Dur-
ing  these  procedures,  the  operator  is  exposed  not  only  to
X-rays  but  also  to  abnormal  fatigue,  which  may  lead  to  a loss
of  concentration.  This  decreased  concentration  may  result
in  delayed  analysis  and,  thus,  a  lengthened  procedure  or
greater  risk  of  complications.  In  addition,  AF  treatment  is
increasingly  used  in  electrophysiological  laboratories,  owing
to  the  prevalence  of  AF  (2—3%  of  the  population  aged
more  than  60  years)  and  the  low  beneﬁt/risk  ratio  of  antiar-
rhythmic  drugs  compared  with  RF  techniques,  as  shown  in
randomized  studies  [2,6—8].
The  future  is  therefore  in  favour  of  a  technology  that
is  at  least  as  effective  as  the  manual  RF  technique  but  has
an  improved  safety  proﬁle  regarding  potential  complications
and  other  variables,  such  as  X-ray  exposure  for  the  patient
and  operator.  Such  technology  should  eventually  allow  for
the  management  of  more  patients  without  affecting  opera-
tor  health.  The  magnetic  navigation  system  (MNS)  appears
to  be  a  futuristic  technology  that  beneﬁts  from  a  very
favourable  beneﬁt/risk  ratio  for  both  the  patient  and  ope-
rator  [6—8]. This  article  aims  to  present  an  overview  of  this
modern  technology,  which  seems  particularly  adapted  to  the
treatment  of  complex  arrhythmias  using  RF.
Description of the system
The  MNS  (Niobe  II;  Stereotaxis,  Inc.,  St.  Louis,  MO,  USA)
is  a  technological  platform  using  a  steerable  magnetic
ﬁeld,  which  remotely  guides  a  supple  catheter  inside  the
heart  [9].  The  steerable  magnetic  ﬁeld  contains  two  giant
computer-controlled  1.8-ton  magnets  positioned  on  oppo-
site  sides  of  the  ﬂuoroscopy  table  (Fig.  1).  A  magnetic  ﬁeld  of
0.08—0.1  Tesla  is  generated  (according  to  the  initial  choice),
such  that  the  three  small  magnets  incorporated  in  parallel
with  the  tip  of  the  RF  catheter  permit  three-dimensional
(3D)  navigation  (Fig.  2).  The  magnetic  ﬁeld  is  applied  to
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Sorated into the catheter tip. Note the extreme ﬂexibility of the
agnetic catheter.
 theoretical  cardiac  volume  of  20  × 20 cm.  The  catheter
ip  may  be  directed  very  precisely  by  using  a  vector-based
omputer  system  (Navigant;  Stereotaxis,  Inc.,  St.  Louis,  MO,
SA)  (Fig.  3).  This  system  operates  by  aligning  the  catheter
elative  to  the  magnetic  ﬁeld  generated,  whereby  the  move-
ents  of  the  catheter  depend  on  changes  in  the  direction
f  the  two  magnets  in  relation  to  each  other.  Advancing
r  retracting  the  catheter  is  controlled  by  a  computerized
otor  drive  system  (Cardiodrive;  Stereotaxis,  Inc.,  St.  Louis,
O,  USA)  (Fig.  4),  while  its  orientation  in  space  requires  a
omputerized  workstation  (Navigant  2.1;  Stereotaxis,  Inc.,
t.  Louis,  MO,  USA)  (Figs.  3  and  4).  Using  a  keypad  (arrows)
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Figure 3. ‘QuickCAS’ Cardiodrive system positioned in the
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ﬁeld,  the  size  of  the  catheters  and  the  absence  of  precise
F
oatient’s groin, permitting the catheter to be advanced by means
f a keypad or joystick, as shown above.
r  joystick,  the  catheter  may  be  continuously  advanced  or
etracted,  or  even  adjusted  (from  1—9  mm).  The  second-
eneration  Niobe  II  allows  the  magnets  to  be  tilted  in
irections  ranging  from  40◦ left  anterior  oblique  to  30◦ right
nterior  oblique.  The  constant  application  of  the  magnetic
eld  during  the  ablation  procedure  keeps  the  catheter  tip  in
ermanent  contact  with  the  endocardial  tissue  throughout
he  cardiac  cycle,  thus  improving  delivery  of  the  RF  cur-
ent.  The  ﬂexibility  and  weak  force  (15—20  g)  exerted  by
he  magnetic  ﬁeld  result  in  reliable  navigation  inside  the
c
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igure 4. Screenshot of the Navigant system, which allows for real-tim
rientation from the keyboard, where the physician works remotely on tA.  Da  Costa  et  al.
eart,  with  a  near-zero  risk  of  perforation  [6—8]. The  sys-
em  is  able  to  memorize  certain  data,  such  as  the  position
f  veins,  and  reutilize  these  vectors  during  the  examina-
ion  to  facilitate  the  navigation  of  the  catheter  or  improve
rocedure  times.  In  addition,  automatic  navigation  is  pos-
ible  using  NaviLine  (Stereotaxis,  Inc.,  St.  Louis,  MO,  USA),
hich  allows  for  automatic  processing  by  producing  a  line
r  surrounding  veins.
The  main  progress  made  over  the  past  months  has  been
o  integrate  a  platform  with  the  3D  mapping  systems  Carto
P,  Cartomerge  and  Carto  3  (Biosense  Webster,  Diamond  Bar,
A,  USA)  (Fig.  5).  With  the  development  of  the  3.5-mm  tip
rrigated  magnetic  catheter,  this  technology  is  being  used
or  the  treatment  of  complex  left  atrial  arrhythmias.  In  this
latform,  the  advantage  of  Carto  3  is  the  visualization  of
ll  the  catheters  and  the  possibility  of  rapid  reconstruction
f  the  anatomical  structures  using  the  magnetic  lasso  tool
Lasso  NAV;  Biosense  Webster,  Diamond  Bar,  CA,  USA).
xperimental studies
he  ﬁrst  experimental  studies  using  a  magnetic  ﬁeld  to  test
he  displacement  of  catheters  were  carried  out  by  Tillander
t  al.  and  then  by  Ram  et  al.,  but  the  attempts  of  these
uthors  were  limited  by  the  weak  force  of  the  magneticontrol  in  three  dimensions  [9,10]. Subsequent  develop-
ents  incorporated  the  use  of  stereotactic  localization  and
ector  control  using  dedicated  software  [11].
e navigation in the different parts of the heart using simple vector
he patient.
Remote  magnetic  navigation  and  arrhythmia  ablation  
Figure 5. Integration of the Carto 3 RMT with the Navigant sys-
tem, permitting instantaneous navigation, with visualization of both
the Navistar RMT catheter and Lasso NAV. The virtual vector in green
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cess  was  obtained  in  this  study  for  38  of  the  40  patients
tested  (i.e.  95%  of  cases).is followed by the catheter vector in yellow.
The  ﬁrst  feasibility  study  carried  out  in  animals  was  pub-
lished  by  Faddis  et  al.  in  2002.  The  authors  studied  MNS
technology  in  the  laboratory  [12]. The  precision  of  the  navi-
gation  system  was  tested  and  shown  to  be  viable  in  six
animals  undergoing  an  RF  procedure,  for  which  51  anatom-
ical  targets  were  tested,  including  the  pulmonary  veins
[12].  Several  variables  were  evaluated,  including  navigation,
deﬂection  force  of  the  catheter,  interference  of  the  elec-
trocardiogram  signal  analysed  during  the  procedure  and  RF
efﬁcacy  [12]. The  authors  showed  that  the  maximal  force
applied  on  the  catheter  was  26.8  g  versus  31.4  g  using  the
manual  method  (limits  of  19.7—45.4  g),  while  navigation
precision  was  possible  in  46/51  of  the  targets  tested  (90%).
The  only  failure  occurred  in  an  animal  in  which  the  aor-
tic  arch  could  not  be  crossed.  To  overcome  this  difﬁculty,
the  magnetic  catheter  was  modiﬁed  by  improving  the  proﬁle
of  the  two  catheter  segments  (ﬂexible  section  and  section
more  rigid).  For  the  30  targets  tested  following  modiﬁcation
of  the  catheter,  the  success  rate  of  lesion  completion  was
29/30  (i.e.  97%  of  the  cases  tested).  During  the  course  of  the
same  procedures,  the  variation  measured  for  the  position  of
the  catheter  with  respect  to  the  target  was  only  0.73  mm.
Navigation  at  the  level  of  the  pulmonary  veins  was  tested  in
ﬁve  animals,  including  30  veins,  and  was  found  to  be  possible
in  100%  of  cases  versus  70%  using  the  manual  method  [12].
The  feasibility  of  the  technology  in  terms  of  obtaining  an
efﬁcacious  lesion  was  validated  as  excellent.  Interference
of  the  signals  studied  via  the  signal/noise  ratio  was  very
small,  despite  the  distortion  exerted  on  the  catheter  and,
above  all,  was  non-signiﬁcant  compared  with  the  manual
method.  A  certain  number  of  limitations  exist  for  this  study,
such  as  the  lack  of  a  randomized  study  design  as  well  as  the
absence  of  evaluation  of  microscopic  lesions  caused  by  RF
treatment  [12].
Greenberg  et  al.  were  the  ﬁrst  researchers  to  test  the
MNS  on  the  electrical  disconnection  of  the  pulmonary  veins
in  animals  (seven  healthy  dogs)  [13]. They  showed  that  elec-
trical  disconnection  of  the  veins  was  possible  in  100%  of  the
cases  without  the  risk  of  pulmonary  vein  stenosis  at  80  days, r449
s  analysed  via  necropsy  and  computed  tomography  scan
13].
Faddis  et  al.  subsequently  conducted  a clinical  feasibility
nd  safety  study  in  31  patients  requiring  ablation  of  com-
lex  arrhythmias,  including  three  patients  with  AF  [14]. In
his  study,  blinded  analysis  showed  that  there  was  no  qua-
itative  difference  in  the  signal  compared  with  the  manual
ethod  [14]. Navigation  in  the  cardiac  cavities  was  possi-
le  in  213/215  sites  tested  on  the  right  (99%)  and  in  13/13
ites  tested  on  the  left,  while  the  levels  of  pacing  thresholds
ere  not  signiﬁcantly  different  between  the  manual  method
nd  the  MNS  [14]. No  complication  was  noted  in  this  study
nd  arrhythmia  ablation  was  possible  in  the  seven  patients
ested  (100%  of  cases)  [14].
Ernst  et  al.  subsequently  investigated  the  feasibility  and
fﬁcacy  of  the  MNS  in  patients  with  intranodal  re-entry
eciprocating  tachycardia  [15]. In  the  42  patients  tested,
nalysis  of  the  slow  potentials  was  possible  in  100%  of  cases,
s  was  ablation  of  the  slow  path  in  100%  of  cases  [15].
he  advantages  of  this  technique  were  underlined  by  the
uthors,  who  highlighted  the  absence  of  the  risk  of  per-
oration,  the  excellent  stability  of  the  catheter  and  the
ossibility  of  navigating  in  complex  anatomical  structures,
uch  as  was  described  for  a  patient  with  persistence  of  the
uperior  vena  cava  associated  with  a giant  ostium  of  the
oronary  sinus  and  a  junctional  tachycardia,  who  was  efﬁ-
aciously  treated  with  the  MNS  [16].
linical studies
uring  the  past  10  years,  ablation  of  AF  has  become  the
ominant  indication  in  centres  of  excellence  and  may
ccount  for  up  to  60%  of  interventions.  The  problem  with
hese  procedures  is  essentially  due  to  the  duration  (at  times
ore  than  4  hours)  and  length  of  exposure  to  X-rays  for  both
perator  and  patient.  The  notably  severe  complications  are
 major  limitation  of  these  techniques,  as  was  shown  by
appato  et  al.  in  their  registry  of  AF  ablation  procedures
ndertaken  in  521  centres  in  24  countries  [17]. Although
F  ablation  was  shown  to  be  efﬁcacious  in  approximately
0%  of  cases,  with  an  average  of  1.3—1.7  procedures  per
atient,  the  rate  of  reported  major  complications  was  4.5%
f  cases,  with  1%  vascular  accidents  and  1.3%  tamponade
17].  It  is  also  necessary  to  take  into  account  the  number
f  procedures  to  be  performed  by  each  operator,  due  to  the
ong-term  risk  of  exposure  to  X-rays.
Clinical  studies  evaluating  the  use  of  the  MNS  in  AF  are
ow  numerous  [18—20]. In  the  initial  phase,  Pappone  et  al.
valuated  the  feasibility  of  the  MNS  in  40  patients  with  AF
rior  to  RF  treatment  [19]. This  was  the  ﬁrst  human  study
onducted  in  the  AF  setting  [19]. In  addition  to  feasibility,
he  authors  demonstrated  the  substantial  efﬁcacy  of  the
obotic  technique,  associated  with  a  signiﬁcantly  decreased
pplication  time  compared  with  the  control  group;  however,
his  was  a  case-control  study  [19]. The  operator  underlined
he  extreme  stability  of  the  magnetic  catheter,  which  was
articularly  useful  for  approaching  straight  veins  [19]. Suc-Di  Biase  et  al.  reported  contradictory  results  in  a  non-
andomized  study  on  45  patients,  while  testing  the  MNS
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sing  a  non-irrigated  4-mm  catheter  [18]. Although  navi-
ation  was  possible  in  most  cases,  the  obtainment  of  vein
isconnection  was  low  (<  90%  of  cases),  mainly  due  to  the
se  of  the  non-irrigated  catheter  [18]. Since  March  2008,
he  irrigated  magnetic  catheter  has  been  commercialized
nd  utilized,  allowing  ablation  results  to  be  compared  with
hose  achieved  using  the  conventional  method  [18]. Schmidt
t  al.  also  showed  that  the  concept  functions  in  AF  patients,
ighlighting  the  quality  of  the  navigation  and  stability  of  the
atheter  [20].
The issue  raised  by  these  authors  refers  to  the  learning
urve,  which  means  that  the  initial  procedures  were  longer
han  those  using  the  conventional  method  [20]. We  have  had
he  same  experience,  as  one  needs  to  get  over  the  learn-
ng  curve  to  obtain  the  large  beneﬁts  associated  with  the
echnology.  The  ﬁrst  100  patient  procedures  performed  in
ur  centre  in  2010  allowed  us  to  achieve  AF  ablation  in  a
onstant  and  reproducible  manner.  Currently,  all  our  RF  AF
rocedures  are  performed  via  stereotaxis  (MNS)  and  there
as  no  need  to  resort  to  the  manual  method  in  the  150
atient  procedures  performed  in  2011.
Katsiyiannis  et  al.  reported  on  their  RF  experience  using
he  MNS  in  AF  patients  in  a  non-randomized  case-control
tudy  [21]. The  authors  presented  very  promising  results
ompared  with  the  manual  technique  by  showing  a  signif-
cant  reduction  in  procedure  time  and  X-ray  exposure,  but
he  catheter  used  was  also  non-irrigated,  thus  resulting  in  a
isk  of  clot  formation  or  ‘char’  formation  [21].
To our  knowledge,  there  is  no  randomized  study  com-
aring  the  manual  method  with  stereotaxis,  particularly
n  the  treatment  of  AF  with  RF.  Recently,  a  study  was
ublished  involving  the  MNS  associated  with  an  irrigated
agnetic  catheter  (Thermocool  Navistar  RMT;  Biosense  Web-
ter,  Diamond  Bar,  CA,  USA)  [22]. A  comparative  study  was
ndertaken  comparing  the  ﬁrst-generation  irrigated  mag-
etic  catheter  with  a  second-generation  irrigated  catheter
hat  had  been  modiﬁed  to  increase  the  internal  lumen
o  facilitate  lavage  [22]. The  initial  ablation  success  rate
as  93%  (26/28  patients)  in  the  new-generation  catheter
roup,  with  a  mean  procedure  time  of  243  minutes  (lim-
ts  125—450  minutes)  and  a  mean  X-ray  exposure  time
f  16  minutes  (limits  8  to  39  minutes)  [22]. During  global
ollow-up,  70%  of  patients  were  in  sinus  rhythm  and  no
omplications  were  observed  with  the  second-generation
atheter.  In  addition,  no  ‘char’  formation  was  detected  in
his  group  of  patients  [22]. A  similar  case-control  study  was
eported  by  Lüthje  et  al.,  involving  107  patients  treated
ith  the  MNS  compared  with  a  group  of  54  patients  treated
anually  [23]. Most  of  the  veins  were  electrically  discon-
ected  in  the  two  groups  (i.e.  in  90%  of  patients).  There
as  a  similar  long-term  success  rate  for  the  two  procedures,
ith  66%  absence  of  AF  in  the  MNS  group  versus  62.1%  in
he  control  group  following  one  single  procedure,  while  the
uccess  rate  was  83%  following  1.5  ±  0.6  procedures  [23].
hile  the  exposure  level  to  X-rays  was  lower  in  the  robotic
roup,  the  procedure  time  was  longer  in  this  study,  as  was
he  radiofrequency  ablation  (RFA)  application  time  [23].
Miyazaki  et  al.  reported  a  case-control  study  evaluat-
ng  30  consecutive  patients  compared  with  44  consecutive
atients  treated  manually  [24]. The  results  were  similar  but
he  procedure  time  for  RFA  was  longer  in  the  MNS  group,
s  was  the  X-ray  exposure  time  (63  ±  18  min  in  the  robotic
s
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roup  vs  47  ±  17  min  in  the  manual  group;  P  =  0.0016).  These
ontradictory  results,  notably  with  respect  to  X-ray  exposure
ime,  may  be  explained  to  some  extent  by  the  opera-
ors’  extensive  experience  with  the  manual  technique,
he  absence  of  the  use  of  a  cartography  system  with  an
xclusive  lasso  technique  and,  ﬁnally,  the  non-randomized
tudy  design  [24]. Pappone  et  al.  reported  their  experience
ith  130  consecutive  patients  using  an  irrigated  magnetic
atheter  (Thermocool  Navistar  RMT)  and  showed  that  abla-
ion  was  possible  in  118/130  patients  (feasibility  of  91%)  with
ecourse  to  a  manual  catheter  in  only  12  cases  (9%)  [25].
he  mean  procedure  time  was  94.6  ±  15.3  minutes  and  the
ong-term  success  rate  (15.3  ±  5  months)  varied  from  81.4%
n  patients  with  paroxysmal  AF  to  67.3%  in  patients  with
ermanent  AF  [25]. No  major  complications  were  reported,
ith  the  exception  of  two  femoral  arteriovenous  ﬁstulas  and
n  important  haematoma  in  the  fold  of  the  groin  [25].
The  use  of  robotics  in  the  RF  treatment  of  complex
rrhythmias  constitutes  one  of  the  most  interesting  appli-
ations,  due  to  the  reduction  in  risk  of  X-ray  exposure
nd  potential  complications.  Nevertheless,  this  technique
s  applicable  to  other  types  of  arrhythmia  [26—42]. Latcu
t  al.  reported  on  84  patients  treated  with  three  types  of
agnetic  catheters  in  different  clinical  situations,  notably
7  intranodal  re-entries,  15  right  isthmus-dependent  ﬂut-
ers,  seven  ventricular  arrhythmias,  three  atrial  arrhythmias
nd  three  cases  of  paroxysmal  AF  [34]. The  overall  success
ate  was  82%  with  a  failure  rate  of  18%  (n  =  14):  seven  right
sthmus-dependent  ﬂutters,  four  accessory  pathways,  two
eft  ﬂutters  after  RFA  of  AF  and  one  intranodal  re-entry.
he  time  of  exposure  to  X-rays  by  the  operator  was  only
.5  ±  0.6  minutes  [34].
The advantages  of  the  MNS  in  the  treatment  of  intranodal
e-entry  tachycardias  have  been  demonstrated  in  numerous
eries  and  were  related,  principally,  to  the  stability  of  the
atheter  [15,16,31,34,37].  It  should  be  noted  that  during
he  application  of  the  RFA  current,  the  appearance  of  a  junc-
ional  rhythm  was  more  rare  [15,31,34,37]. The  efﬁcacy  and
afety  of  the  MNS  in  this  indication  is  evident  in  light  of  the
ifferent  series  published  from  different  centres,  although
one  of  the  studies  was  randomized  [15,16,31,34,37].
The  use  of  the  MNS  in  right  isthmus-dependent  ﬂutter
as  been  investigated  in  several  series  in  the  form  of  reg-
stries,  with  only  two  randomized  studies  being  published
36,41].  Vollman  et  al.  randomized  45  patients  with  right
sthmus-dependent  ﬂutter,  with  each  group  being  treated
ith  an  8-mm  catheter;  the  authors  obtained  a  bidirec-
ional  isthmus  block  in  84%  using  the  MNS  and  in  91%  using
he  manual  method  [41]. The  authors  showed  that  proce-
ure  times  and  application  durations  were  longer  with  the
NS  compared  with  the  conventional  method,  whereas  X-ray
xposure  time  was  largely  and  signiﬁcantly  lower  with  the
NS  (median  10  vs  15  minutes;  P  <  0.05)  [41]. One  interpreta-
ion  of  these  data  is  that  the  force  applied  by  the  magnetic
ystem  on  the  cavotricuspid  isthmus  was  insufﬁcient  with
espect  to  the  thickness  and  complexity  of  the  local  anatomy
28,30,38,41].
The  MNS  has  been  tested  in  the  treatment  of  the  acces-
ory  pathways  in  several  studies,  the  most  important  of
hich  was  published  by  Chun  et  al.,  but  none  of  the  stud-
es  was  randomized  [28,29,32,39,42].  Three  generations  of
agnetic  catheters  were  tested  and  showed  an  elevated
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success  rate  with  the  last  generation  of  magnetic  catheters
(92%  vs  85%  with  the  second-generation  catheters  and  only
a  67%  success  rate  with  the  ﬁrst-generation  catheters)  [28].
The  main  difference  between  a  ﬁrst-generation  catheter  and
the  second-  and  third-generation  catheters  is  the  number  of
magnets  integrated  in  the  catheter,  with  three  magnets  for
the  new-generation  catheters.  The  placement  at  the  level
of  the  registering  electrodes  was  then  optimized  with  the
positioning  of  two  proximal  electrodes  in  the  last  version,
permitting  the  simultaneous  recording  of  proximal  and  distal
signals  [28].
A particular  beneﬁt  of  the  MNS  in  the  ablation  of  the
accessory  parahissian  pathways  has  been  shown  in  particu-
lar  cases;  this  observation  underlines  the  advantage  of  this
technology  based  upon  the  stability  and  precision  of  the
magnetic  catheter  [29,32,42].
The feasibility,  efﬁcacy  and  safety  of  the  MNS  have
been  tested  in  almost  all  indications  at  the  auricular  level
and  some  studies  were  performed  at  the  ventricular  level
[33,39].  Limited  but  efﬁcacious  experiences  with  RFA  were
reported  in  the  treatment  of  benign  infundibular  ventri-
cular  extrasystoles,  where  the  feasibility  of  the  technology
was  similar  to  reported  series  using  the  conventional  method
[33,39].
A  few  studies  on  the  efﬁcacy  of  the  treatment  in  cases  of
ischaemic  ventricular  arrhythmias  have  been  published  [26].
In  addition,  isolated  cases  have  been  reported  in  particular
clinical  situations,  such  as  fascicular  ventricular  arrhythmia,
ventricular  extrasystoles  localized  at  the  level  of  the  left
anterior  aortic  sigmoid,  left  atrial  arrhythmias  or  re-entrant
arrhythmias  associated  with  congenital  cardiopathies  and,
ﬁnally,  in  the  treatment  of  epicardial  ventricular  arrhyth-
mias  [27,35,40,43—45].
Advantages of the robotic magnetic
navigation system
Fluoroscopy
One  of  the  principal  advantages  that  emerged  during  our
review  of  the  literature  is  represented  by  the  highly  sig-
niﬁcant  decrease  in  the  duration  of  exposure  to  X-rays
[22,41,42]. In  the  short  term,  this  observation  may  appear
to  be  trivial  for  patients  but  in  the  case  of  multiple  inter-
ventions  using  radiation  it  could  represent  a  very  signiﬁcant
decrease  in  X-ray  exposure  for  the  physician  [22,41,42]. This
analysis  is  even  truer  for  electrophysiologists,  who  often
exert  multidisciplinary  activities  with  implantation  of  resyn-
chronization  devices  and  ablation  of  complex  arrhythmias;
in  the  long  term,  this  beneﬁt  becomes  obvious  [46]. The
amplitude  of  the  reduction  in  X-ray  exposure  was  evalu-
ated  to  be  50%  on  average  [22,41,42]. Very  similar  results
were  published  by  Kim  et  al.,  with  an  average  reduction  of
29  minutes  compared  with  the  conventional  method  [46].
Procedure timeProcedure  times  appear  to  be  longer  than  those  of  the  con-
ventional  method  but  a  certain  number  of  biases  exist  in
the  studies.  In  fact,  the  studies  were  performed  with  more
experienced  groups,  generally  involving  several  operators,
t
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ncluding  ‘fellows’,  and  the  learning  curve  was  integrated,
hich  makes  analysis  of  the  results  difﬁcult.  Although  the
rocedure  time  appears  to  be  determinant,  one  should
robably  include  operator  fatigue  in  the  evaluation.  In  retro-
pect,  it  appears  to  us  that  the  contribution  of  the  MNS  was
ajor  concerning  this  variable,  allowing  us  to  signiﬁcantly
ncrease  our  activity,  while  reducing  the  level  of  fatigue  at
he  end  of  the  day.  Di  Biase  et  al.  showed  that  the  MNS  very
igniﬁcantly  reduced  ﬂuoroscopy  time  during  ablation  of  AF
nd,  when  the  learning  curve  was  overcome,  there  was  an
dditional  improvement  [18].
afety
tilization  of  the  magnetic  catheter,  for  which  ﬂexibility
s  a  major  asset,  has  considerably  increased  the  safety  of
omplex  procedures  such  as  RFA  in  AF  [20,47]. The  risk  of
erforation  is  almost  absent,  mainly  due  to  the  catheter
oftness  rather  than  to  the  constant  force  applied  to  the
issue,  evaluated  as  being  maximally  15—20  g  [12,20]. Cases
f  tamponade  due  to  the  catheter  are  very  rare  in  the  lit-
rature  [20,47].  The  use  of  this  tool  in  daily  practice  in
ll  of  the  AF  ablation  procedures  has  maximized  safety  for
he  patients  and  serenity  for  the  operators  in  our  centre.
n  approximately  250  cases  of  AF  ablation  carried  out  in
ur  laboratory  using  the  stereotaxic  system,  we  had,  unfor-
unately,  one  case  of  tamponade,  which  occurred  during
 transseptal  catheterization.  One  theoretical  advantage,
hich  in  not  quantiﬁable  for  the  moment,  is  the  absence
f  iterative  sheath  mobilization  during  the  procedure  to
revent  complications  such  as  potential  clot  mobilization,
hich  could  limit  the  risk  of  emboli.
fﬁcacy
he  results  presented  in  the  different  studies  appear  to  be
imilar  to  those  for  the  conventional  method  but  they  are
ot,  for  the  moment,  superior  [47]. One  needs  to  interpret
hese  results  in  the  actual  context,  where  the  experience  of
he  operators  is  considerably  less  compared  with  the  manual
ethod  [47]. In  addition,  we  must  wait  for  the  outcome  of
rospective  studies  using  the  two  methods  in  experienced
entres  to  really  answer  the  question,  because  certain  the-
retical  advantages  appear  to  favour  the  MNS,  such  as  the
tability  of  the  catheter,  access  to  difﬁcult  zones  such  as  the
ight  inferior  pulmonary  vein,  the  quality  of  the  practiced
ines  and  homogeneity  of  the  lesions  [47].
imitations of the robotic magnetic
avigation system
he  principal  inconvenience  is  related  to  the  cost  of  the
nstallation,  which  may  be  up  to  two  million  euros  if  a  de-
icated  room  is  taken  into  account.  This  cost  needs  to  be
alanced  with  the  numerous  long-term  advantages,  namely
he  efﬁcacy,  safety  and,  once  again,  reduction  in  X-ray  expo-
ure.  This  is  a  futuristic  technology  that  is  perfectly  adapted
o  the  treatment  of  complex  arrhythmias  and,  more  princi-
ally,  to  the  treatment  of  AF  by  RF.
The  second  limitation  is  the  initial  captive  nature  of  the
ystem,  exhibiting  compatibility  only  with  Cordis  Webster
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atheters  and  the  Carto  XP,  Cartomerge  and  Carto  3  RMT
ard  systems.  Nowadays,  the  system  is  compatible  with  NavX
Endocardial  Solutions,  St.  Jude  Medical,  Inc.,  St.  Paul,  MN,
SA)  or  can  even  use  a  magnetic  catheter  made  by  other
ompanies  (Biotronik  and  others).
Finally,  the  presence  of  a  stimulation  or  cardiac  deﬁb-
illation  device  makes  the  operator  reluctant  to  carry  out
 stereotaxic  procedure  [48,49].  A  recent  study  involving
21  devices  showed  that  the  risk  of  interference  was,  in
eality,  very  small,  as  95%  of  devices  did  not  show  any
nterference  with  the  programme  variables,  battery  status
r  registered  data  [49]. Interference  was  observed  in  six
atients  with  pacemakers,  requiring  simple  reprogramming
49]. A  retrospective  study  was  published  on  31  patients  with
acemakers  (n  =  5)  and  deﬁbrillators  (n  =  36)  by  Eitel  et  al.,
emonstrating  the  safety  of  the  system  with  the  restrictions
ssociated  with  the  number  of  patients  in  the  study  [48].
hese  results  are  in  accordance  with  the  data,  which  show
hat  the  magnetic  ﬁeld  emitted  by  the  stereotaxic  system
s  20—40  times  weaker  than  that  associated  with  magnetic
esonance  imaging  [49].
Other  limits  were  evoked  by  Miyazaki  et  al.  in  the  treat-
ent  of  AF,  such  as  the  longer  placement  phase,  the  need
or  the  operator  to  move  for  the  positioning  of  the  lasso,
he  restricted  contact  force  that  may  limit  the  size  of  the
esion,  the  use  of  a  supplementary  sheath  for  the  ablation
nd  the  cost  of  the  procedure  in  relation  to  the  manual  lasso
echnique  [24]. These  disadvantages  are  not  evident  in  very
xperienced  teams  and  in  light  of  the  important  develop-
ents  made  over  the  last  months,  with  the  release  of  the
atest  version  of  the  Niobe  ES  (Epoch)  system  (Stereotaxis,
nc.,  St.  Louis,  MO,  USA),  which  increases  by  500%  the  exe-
ution  speed  of  the  magnetic  catheter  with  respect  to  the
arlier  version,  and  the  associated  commercialization  of  the
-drive  system,  which  allows  the  lasso  to  be  manipulated  in
n  automated  manner  at  a  distance.
onclusion
he  treatment  of  complex  arrhythmias  such  as  AF  accounts
or  the  major  portion  of  the  ablations  that  will  be  carried  out
y  electrophysiological  laboratories  in  the  future.  Over  the
ast  few  years,  the  robotic  MNS  (NIOBE  II)  has  emerged  as
 modern  technology  particularly  adapted  to  the  treatment
f  complex  arrhythmias,  exhibiting  an  equivalent  efﬁcacy
o  the  manual  technique  in  all  of  the  clinical  studies.  The
obotic  MNS  allows  for  a  considerable  reduction  in  X-ray
xposure  and  risk  of  severe  complications,  essentially  tam-
onade.  The  beneﬁt  is  expected  for  the  patient  but  also  for
he  operator,  whose  level  of  physical  constraint  and  ensuing
atigue  is  largely  reduced  by  the  system.
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